The Regulators

Four Case Studies

CRTC — Telecommunications

Highest Wireless Prices in the Developed World

The Canadian Radio-television and Telecommunications Commission regulates the telecommunications industry. Canadians pay among the highest wireless and broadband prices in the developed world. CRTC commissioners have historically included individuals with prior careers at the telecommunications companies being regulated. Regulatory decisions — including spectrum allocation, foreign ownership restrictions, and wholesale access rates — have consistently favoured incumbent carriers (Rogers, Bell, Telus) over new entrants and consumers. The CRTC's mandate includes promoting competition, but market concentration has increased rather than decreased under its oversight. Three companies control approximately 87% of the wireless market.

CER — Energy

From National Energy Board to Canada Energy Regulator

The Canada Energy Regulator (formerly the National Energy Board) regulates pipelines, energy exports, and related infrastructure. The CER board includes members with extensive energy industry experience — which proponents argue is necessary for technical competence, and critics argue creates regulatory capture. Major pipeline decisions (Trans Mountain, Coastal GasLink) have been approved despite significant opposition. The regulatory process is funded primarily by the industries being regulated through cost recovery mechanisms. Environmental and Indigenous interveners face significant resource barriers to meaningful participation in regulatory proceedings.

OSFI — Banking

Regulating the Banks That Fund the Regulators

The Office of the Superintendent of Financial Institutions regulates Canadian banks, insurance companies, and pension plans. OSFI's operational costs are recovered from the financial institutions it regulates — meaning the regulated entities directly fund their regulator. OSFI leadership has historically included individuals from the banking sector. The stress testing methodology used to assess bank resilience is developed in collaboration with the banks being tested. Canada's "Big Five" banks are among the most profitable financial institutions globally, with combined annual profits exceeding $50 billion. The regulatory framework has maintained banking stability but has also maintained extraordinary profitability and market concentration.

PMPRB — Pharmaceuticals

Drug Prices That Never Come Down

The Patented Medicine Prices Review Board is mandated to ensure that patented medicines are not sold at excessive prices. Canada's drug prices rank among the highest in the OECD. The PMPRB's reform efforts — including revised price comparison methodologies announced in 2019 — have faced extensive industry legal challenges and implementation delays. The pharmaceutical industry's lobbying infrastructure is well-documented in the federal lobbying registry. The result: a regulatory body mandated to control drug prices that has been unable to bring Canadian prices in line with international comparators despite years of reform efforts.

Structural Mechanisms

How Capture Works

Mechanism 1: The Revolving Door

Regulatory appointments draw from a pool of individuals with industry expertise — which in practice means industry careers. After serving as regulators, many return to the private sector, often to the industries they regulated. This creates an incentive structure where regulatory decision-makers have personal and professional relationships with the entities they regulate, and future career prospects that depend on maintaining industry goodwill. Cooling-off periods exist but are limited in duration and scope.

Mechanism 2: Industry-Funded Processes

Major regulatory bodies recover their operational costs from the industries they regulate. OSFI is funded by financial institution assessments. CER proceedings are funded by proponent cost recovery. CRTC licensing fees are paid by broadcasters and telecoms. When the regulator's funding comes from the regulated industry, the financial dependency creates a structural alignment of interests — not necessarily corruption, but a systemic bias toward outcomes that maintain the regulated industry's willingness and ability to fund the regulatory process.

Mechanism 3: Asymmetric Access

Regulated industries have effectively unlimited resources to participate in regulatory proceedings: legal teams, expert witnesses, economic models, and lobbying infrastructure. Public interest groups, consumer advocates, and Indigenous communities participate with fraction of those resources. Regulatory proceedings are technically open to all parties, but the quality and quantity of participation is determined by financial capacity. The result: regulatory records dominated by industry submissions, with public interest perspectives underrepresented in the evidentiary record that drives decisions.

The Capture Architecture

Regulatory capture is where institutional capture meets democratic deficit. The government appoints the regulators. Industry influences the government. The regulators serve the industry. The public pays.

The accountability scorecard shows oversight bodies cannot enforce against government. Regulatory capture shows regulatory bodies do not enforce against industry. Both represent the same structural architecture: institutions designed for accountability that produce outcomes aligned with the interests they are supposed to constrain.

[CONNECTED INTELLIGENCE]

Synthesis
Institutional Capture
Oversight
Crown Corp Oversight
PM
Carney & the Global Order
Healthcare
Healthcare Privatization
Democracy
Democratic Deficit
Reference
Accountability Scorecard
Related
Media Capture
Influence
Lobbying Industrial Complex
Sources: CRTC — Annual Reports, Telecom Decision Records, Spectrum Allocation Decisions; Canada Energy Regulator — Annual Reports and Hearing Decisions; OSFI — Annual Reports and Supervisory Framework; Patented Medicine Prices Review Board — Annual Reports and Reform Documents; Office of the Commissioner of Lobbying — Federal Lobbying Registry; Statistics Canada — Telecommunications Pricing Data; OECD — Communications Outlook, Health at a Glance (Drug Pricing); Competition Bureau — Market Study Reports; House of Commons Standing Committees — Testimony on Regulatory Bodies. All data from official regulatory records, published decisions, and government statistics.